Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
23.81
-0.49 (-2.02%)
Feb 23, 2026, 12:37 PM EST - Market open
Catalyst Pharmaceuticals Revenue
Catalyst Pharmaceuticals had revenue of $148.39M in the quarter ending September 30, 2025, with 15.31% growth. This brings the company's revenue in the last twelve months to $578.20M, up 25.56% year-over-year. In the year 2024, Catalyst Pharmaceuticals had annual revenue of $491.73M with 23.49% growth.
Revenue (ttm)
$578.20M
Revenue Growth
+25.56%
P/S Ratio
5.17
Revenue / Employee
$3,194,453
Employees
181
Market Cap
2.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 491.73M | 93.53M | 23.49% |
| Dec 31, 2023 | 398.20M | 184.00M | 85.90% |
| Dec 31, 2022 | 214.20M | 73.37M | 52.10% |
| Dec 31, 2021 | 140.83M | 21.76M | 18.27% |
| Dec 31, 2020 | 119.07M | 16.77M | 16.39% |
| Dec 31, 2019 | 102.31M | 101.81M | 20,361.20% |
| Dec 31, 2018 | 500.00K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 488.96K | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apellis Pharmaceuticals | 1.02B |
| Travere Therapeutics | 490.73M |
| Tarsus Pharmaceuticals | 366.10M |
| Arcutis Biotherapeutics | 317.93M |
| IDEAYA Biosciences | 218.71M |
| Liquidia | 69.22M |
| Beam Therapeutics | 55.70M |
| Xenon Pharmaceuticals | 7.50M |
CPRX News
- 4 days ago - Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs - Seeking Alpha
- 12 days ago - Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 5 weeks ago - Catalyst Pharmaceuticals, Inc. (CPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals, Inc. (CPRX) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 months ago - Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - GlobeNewsWire